# Zota Health Care (NSE: ZOTA) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/ZOTA · Pivot · prices to 22 Oct 2026

Zota Health Care (NSE: ZOTA) closed at ₹1,304.00 on 22 Oct 2026, down 0.76% on the day. With a market capitalisation of ₹4,516 Cr, it ranks 820th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Biotechnology.

Its return on equity was −10.7% in FY26. Over the past year the share price has fallen 12.1%. Its 52-week range is ₹1,022.00 (2 Sep 2026) to ₹1,740.00 (21 Nov 2025); the last close is 25.1% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹163 Cr (+67.8% year on year) and net profit −₹14 Cr, on a consolidated basis. Promoters held 49.38% of the company as of 30 Jun 2026; 0.26% of promoter shares were pledged.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹1,304.00 |
| Market cap | ₹4,516 Cr |
| ROE | −10.7% (FY26) |
| ROCE | −6.3% (FY26) |
| Debt to equity | 0.04 |
| 52-week high | ₹1,740.00 (21 Nov 2025) |
| 52-week low | ₹1,022.00 (2 Sep 2026) |
| 1-year return | −12.1% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹163 Cr | +67.8% | −₹14 Cr | — | −₹4.13 |
| Q3 FY26 | ₹143 Cr | +98.2% | −₹30 Cr | — | −₹9.44 |
| Q2 FY26 | ₹129 Cr | +91.7% | −₹16 Cr | — | −₹5.26 |
| Q1 FY26 | ₹104 Cr | +84.0% | −₹14 Cr | — | −₹4.92 |
| Q4 FY25 | ₹97 Cr | +96.0% | −₹13 Cr | — | −₹4.57 |
| Q3 FY25 | ₹72 Cr | +53.7% | −₹19 Cr | — | −₹6.80 |
| Q2 FY25 | ₹67 Cr | +48.6% | −₹12 Cr | — | −₹4.57 |
| Q1 FY25 | ₹56 Cr | +45.7% | −₹13 Cr | — | −₹4.80 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹293 Cr | −₹57 Cr |
| FY24 | ₹180 Cr | −₹14 Cr |
| FY23 | ₹140 Cr | −₹6 Cr |
| FY22 | ₹131 Cr | ₹9 Cr |
| FY21 | ₹107 Cr | −₹0 Cr |
| FY20 | ₹95 Cr | ₹3 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 49.38%
- Foreign institutions: 7.92%
- Domestic institutions: 6.75%
- Non-institutions: 35.96%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [IOL Chemicals and Pharmaceuticals](https://app.pivotnow.in/stock/IOLCP) | ₹173.27 | ₹5,086 Cr | 36.9 | — |
| [RPG Life Sciences](https://app.pivotnow.in/stock/RPGLIFE) | ₹2,754.80 | ₹4,556 Cr | 39.6 | — |
| [Jeena Sikho Lifecare](https://app.pivotnow.in/stock/JSLL) | ₹360.05 | ₹4,475 Cr | 20.3 | — |
| [Novartis India](https://app.pivotnow.in/stock/NOVARTIND) | ₹1,810.70 | ₹4,471 Cr | 48 | — |
| [Orchid Pharma](https://app.pivotnow.in/stock/ORCHPHARMA) | ₹876.25 | ₹4,444 Cr | 214.2 | — |
| [SMS Pharmaceuticals](https://app.pivotnow.in/stock/SMSPHARMA) | ₹434.55 | ₹4,070 Cr | 39 | — |

## Questions and answers

### What is the share price of Zota Health Care today?

Zota Health Care (NSE: ZOTA) last closed at ₹1,304.00 on 22 Oct 2026. Its 52-week high is ₹1,740.00 and its 52-week low is ₹1,022.00.

### What is the market cap of Zota Health Care?

Zota Health Care's market capitalisation is ₹4,516 Cr (₹4,516 Cr) at the 22 Oct 2026 close, ranking 820th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Zota Health Care?

Return on equity was −10.7% in FY26 and return on capital employed was −6.3% in FY26 (consolidated figures).

### Is Zota Health Care a debt-free company?

Zota Health Care is close to debt-free: its debt-to-equity ratio was 0.04 in FY26.

### What were Zota Health Care's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Zota Health Care reported revenue of ₹163 Cr, +67.8% year on year, and net profit of −₹14 Cr.

### How has Zota Health Care stock performed over the last year?

Zota Health Care's share price has fallen 12.1% over the past year, +2.3% over three months and −0.5% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Zota Health Care?

As of 30 Jun 2026: promoters 49.38%, foreign institutions 7.92%, domestic institutions 6.75%, non-institutions 35.96%. 0.26% of promoter shares were pledged.

### Who are Zota Health Care's competitors?

The listed Pharma & Healthcare companies closest to Zota Health Care by market cap are IOL Chemicals and Pharmaceuticals, RPG Life Sciences, Jeena Sikho Lifecare, Novartis India, Orchid Pharma and SMS Pharmaceuticals.

### Is Zota Health Care a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Zota Health Care's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ZOTA against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.